| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/10/2010 | WO2010066815A3 Encapsulating system for cest imaging with chelate q greater than or equal to 2 |
| 09/10/2010 | WO2010039609A3 Conjugates of hexose and metal coordinating compounds for imaging purposes |
| 09/10/2010 | CA2754072A1 Methods and products for in vivo enzyme profiling |
| 09/09/2010 | US20100228007 Mhc-peptide complex binding ligands |
| 09/09/2010 | US20100226974 Antibody recognizing antigen |
| 09/09/2010 | US20100226914 Method for preparation of single chain antibodies |
| 09/09/2010 | US20100226861 Topical composition detection |
| 09/09/2010 | US20100226860 Neuromyelitis optica autoantibodies as a marker for neoplasia |
| 09/09/2010 | US20100226858 Method of predicting a predisposition to qt prolongation |
| 09/09/2010 | US20100226857 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites |
| 09/09/2010 | US20100226856 Dynamic bio-nanoparticle elements |
| 09/09/2010 | US20100226855 Rate-Controlled Oral Dosage Formulations |
| 09/09/2010 | US20100226852 Clk-peptide and slk-peptide |
| 09/08/2010 | EP2226082A2 Control of the toxicity of gold nanoparticles |
| 09/08/2010 | EP2225271A2 New non-selective somatostatin analogues |
| 09/08/2010 | EP2224962A2 Non-spherical contrast agents for cest mri based on bulk magnetic susceptibility effect |
| 09/08/2010 | EP2224960A2 Method of treating cancer |
| 09/08/2010 | EP1991503B1 Method of preparation of superparamagnetic nanoparticles based on iron oxides with modified surface and superparamagnetic nanoparticles obtained by such a method |
| 09/08/2010 | EP1590006B1 Ultrasound contrast agents and process for the preparation thereof |
| 09/08/2010 | EP1478667B1 Anti-human tenascin monoclonal antibody |
| 09/08/2010 | EP1429797B1 Diagnosis and treatment of malignant neoplasms |
| 09/08/2010 | CN101824090A Monoclonal antibody hpam4 |
| 09/08/2010 | CN101822846A Magneto-optical dual-mode molecular image probe and preparation method thereof |
| 09/08/2010 | CN101822838A Nano-medicament carrier material for target recognition of tumor cell as well as preparation and application thereof |
| 09/08/2010 | CN101475224B Preparation of polyvinyl pyrrolidon modified superparamagnetism nano bengala |
| 09/07/2010 | US7792569 Cavity-filling biopsy site markers |
| 09/07/2010 | US7790860 Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids |
| 09/07/2010 | US7790669 Parkinson's disease, Alzheimer's disease or Huntington's disease or a neurological injury that results from ischemia such as a stroke; tissue repair |
| 09/07/2010 | US7790362 Prostaglandin E1 as platelet inhibitor; signal transduction; solid phase synthesis; kits |
| 09/07/2010 | US7790162 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
| 09/07/2010 | US7790145 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent |
| 09/07/2010 | US7790144 Receptor-avid exogenous optical contrast and therapeutic agents |
| 09/07/2010 | US7790143 One or more antigen preparations from bacterial species having 16S rRNA sequence with at least 93% sequence identity to Candidatus Helicobacter suis; Helicobacter felis, salomonis, heilmannii, cynogastricus, baculiformis; whole-killed, attenuated, sonication lysis; in vivo propagation; oral, parenteral |
| 09/07/2010 | US7790141 oligomeric, homopolymeric, water soluble, hydrolytically stable and non-ionic compounds and compositions useful in medical diagnostic and pharmaceutical field in drug delivery, imaging |
| 09/07/2010 | CA2490326C Photodynamic therapy for vascular diseases |
| 09/07/2010 | CA2259156C Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 09/02/2010 | WO2010099137A2 In situ methods for monitoring the emt status of tumor cells in vivo |
| 09/02/2010 | WO2010098502A1 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases |
| 09/02/2010 | WO2010098435A1 Method and kit for detecting cancer-metastasized site, and method for treating cancer using the method or kit |
| 09/02/2010 | WO2010096930A1 Single chain antibodies for targeting pancreatic alpha and beta cells |
| 09/02/2010 | WO2010023670A3 Methods for covalently attaching a polymer to a methionine residue in proteins and peptides |
| 09/02/2010 | US20100223678 protein isoforms of the pif-family and uses thereof |
| 09/02/2010 | US20100222657 Method for glucose monitoring using fluorescence quenching |
| 09/02/2010 | US20100221193 Color change surgical prep solution |
| 09/02/2010 | US20100221192 Contrast agents |
| 09/02/2010 | US20100221191 Contrast agents |
| 09/02/2010 | US20100221190 Method for producing a particle comprising a gas core and a shell and particles thus obtained |
| 09/02/2010 | US20100221189 Contrast agents |
| 09/02/2010 | US20100221188 Coated sensors and methods related thereto |
| 09/02/2010 | US20100221187 Treatment of amyloidogenic diseases |
| 09/02/2010 | US20100221186 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds |
| 09/02/2010 | US20100221185 Vaccines and vaccine components for inhibition of microbial cells |
| 09/02/2010 | US20100221184 Compositions for Delivery of Therapeutics and Other Materials |
| 09/02/2010 | US20100221183 Peptides for treating and diagnosing cancers and methods for using the same |
| 09/02/2010 | US20100221181 Method of differentially diagnosing different types of dementia |
| 09/02/2010 | US20100221180 In vivo imaging of myelination |
| 09/02/2010 | US20100221179 IL-1 Binding Proteins |
| 09/02/2010 | US20100221177 RS7 Antibodies |
| 09/02/2010 | US20100221176 Methods and compositions for protein labelling |
| 09/01/2010 | EP2223939A1 Transgenic mice used as models for human pathologies originating from stem cells |
| 09/01/2010 | EP2223110A1 Markers of matrix gene expression and cellular differentiation in chondrocytes |
| 09/01/2010 | EP2222689A1 Compounds for therapy and diagnosis |
| 09/01/2010 | EP2222346A1 Mr imaging agent, imaging medium and methods of imaging wherein such an imaging medium is used |
| 09/01/2010 | EP2222345A1 Methods for detecting lung cancer and monitoring treatment response |
| 09/01/2010 | EP1706158B1 Medical devices visible under magnetic resonance imaging |
| 09/01/2010 | EP1629105B1 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells |
| 09/01/2010 | EP0711179B2 Stabilized microbubble compositions for ultrasound |
| 09/01/2010 | CN101821231A Contrast agents |
| 09/01/2010 | CN101820924A Contrast agents |
| 09/01/2010 | CN101820923A Contrast agents |
| 09/01/2010 | CN101820922A Contrast agents |
| 09/01/2010 | CN101818128A Superparamagnetic iron oxide labeled human pancreas cancer cell strain as well as labeling method and application thereof |
| 09/01/2010 | CN101816795A Nanometer magnetic control throat anesthesia compound preparation and use thereof |
| 09/01/2010 | CN101816576A Closed loop muscle relaxation iatrical effect monitoring and injecting method and closed loop muscle relaxation injecting device |
| 09/01/2010 | CN101313869B Testing instrument for cold-hot drink of large mouse |
| 08/31/2010 | US7786286 Microorganismal, outer-membrane, enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection |
| 08/31/2010 | US7786167 Compositions containing prodrugs of florfenicol and methods of use |
| 08/31/2010 | US7785571 Treatment of fungal infections |
| 08/31/2010 | US7785570 Combination vaccine for poultry |
| 08/31/2010 | US7785569 Measuring stomach discharging; analyzing emisison in breath; calibration |
| 08/31/2010 | US7785568 Sterically stabilized liposomes with hydrophilic polymers on surface; computed tomography |
| 08/31/2010 | US7785567 treatment of hypercholesterolemia or cardiovascular disease associated with atherosclerosis by administration of Growth Hormone Releasing Peptides to patient; reducing blood plasma cholesterol levels; modulating expression of scavenger receptor CD36 and genes involved in cellular cholesterol efflux |
| 08/31/2010 | US7785566 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II |
| 08/31/2010 | CA2323743C Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 08/26/2010 | WO2010096733A2 Luminescent porous silicon nanoparticles, methods of making and using same |
| 08/26/2010 | WO2010096572A2 Synthetic diblock copolypeptide hydrogels for use in the central nervous system |
| 08/26/2010 | WO2010096464A1 Gold/lanthanide nanoparticle conjugates and uses thereof |
| 08/26/2010 | WO2010096426A2 Compounds, compositions, methods of synthesis, and methods of treatment |
| 08/26/2010 | WO2010095940A2 Glutathione-based drug delivery system |
| 08/26/2010 | WO2010095461A1 Novel monoclonal antibody, and use thereof |
| 08/26/2010 | US20100215665 Mixed lineage kinases and metabolic disorders |
| 08/26/2010 | US20100215587 Materials and methods for mri contrast agents and drug delivery |
| 08/26/2010 | US20100215586 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilizing layer coupled to hydrophilic biodistribution ligands |
| 08/26/2010 | US20100215585 Dyes and precursors and conjugates thereof |
| 08/26/2010 | US20100215584 Compositions and methods of modulating the taste and smell receptors and screening methods therefore |
| 08/26/2010 | US20100215583 Cell nucleus-entering compositions |
| 08/26/2010 | US20100215582 Liposome and method for producing liposome |
| 08/26/2010 | US20100215581 Contrast agents for detecting prostate cancer |
| 08/26/2010 | US20100215580 Compositions and methods for enhancing transport through mucus |
| 08/26/2010 | US20100215577 Compositions and methods for visualizing and eliminating cancer stem cells |